New leukemia treatment "exceeded our wildest expectations"
From the article:<p>"Both the National Cancer Institute and several pharmaceutical companies declined to pay for the research. Neither applicants nor funders discuss the reasons an application is turned down. But good guesses are the general shortage of funds and the concept tried in this experiment was too novel and, thus, too risky for consideration."<p>The keywords are "experiment was too novel, and thus, too risky for consideration". Unfortunately, this seems to have become the rule rather than the exception in scientific research. All the young folks (pre-tenure) are on a treadmill to get funding and publish <i>something</i> in the top journals/conferences. I wish there was some accountability in the system ... the geniuses who rejected funding this research will go about completely unaffected.